Cardinal Health Cash & Equivalents increased by 41.8% to $3.94B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 18.4%, from $3.33B to $3.94B. Over 4 years (FY 2021 to FY 2025), Cash & Equivalents shows an upward trend with a 3.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase signals improved liquidity and financial flexibility, while a decrease may indicate heavy capital expenditure, debt repayment, or aggressive share buybacks.
Represents the most liquid assets on the balance sheet, including physical currency and short-term investments with matu...
Large-cap technology peers often maintain high cash balances to fund rapid innovation and offset the cyclical nature of consumer electronics.
cash_and_equivalents| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.41B | $2.46B | $3.16B | $2.36B | $4.72B | $3.49B | $3.65B | $3.99B | $4.04B | $3.85B | $4.59B | $3.72B | $5.13B | $2.87B | $3.81B | $3.33B | $3.87B | $4.59B | $2.78B | $3.94B |
| QoQ Change | — | -27.7% | +28.3% | -25.5% | +100.2% | -26.0% | +4.6% | +9.2% | +1.3% | -4.7% | +19.1% | -19.0% | +38.1% | -44.1% | +32.9% | -12.7% | +16.5% | +18.6% | -39.5% | +41.8% |
| YoY Change | — | — | — | — | +38.5% | +41.8% | +15.6% | +69.4% | -14.3% | +10.4% | +25.6% | -6.8% | +27.0% | -25.6% | -17.0% | -10.5% | -24.5% | +60.2% | -27.1% | +18.4% |